CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.86 ($24,300)
- 4 Gift Director gave 200,000 shares (gift)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.73 ($37,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition COO & CFO acquired 1,918 shares (other)
- 4 Open-market buy Director bought 40,000 shares at $2.08 ($83,200)
- 4 Open-market buy Chief Executive Officer bought 28,000 shares at $2.11 ($59,080)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 24,500 shares at $2.27 ($55,615)
- 4 Open-market buy Director bought 31,083 shares at $2.27 ($70,558)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.03 ($40,600)
- 4 Other acquisition COO & CFO acquired 1,867 shares (other)
- 4 Open-market buy Director bought 5,799 shares at $2.12 ($12,294)
- 4 Open-market buy Director bought 10,000 shares at $1.84 ($18,400)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $1.82 ($36,400)
Page 7 of 24 · 471 filings